Greiner Bio-One webinars
Greiner Bio-One offers educational webinars for both BioScience and Preanalytics customers several times throughout the year at no charge to industry professionals. These webinars are recorded and made available to customers to enjoy in the future.
Please note that recordings for Preanalytics webinars are available for a maximum of 7 days after the live event due to the requests of our speakers. When available, these recordings will be listed here.
Optimising transfection as a starting point for bioproduction
Bioproduction describes the manufacturing process of biological compounds such as recombinant proteins or antibodies. Essential for all subsequent processing steps is the establishment of a well-performing starter culture. An optimised transfection in small scale is one of the first steps to successfully create a stable or transiently protein-producing cell line.
In this webinar, we will give an overview on the bioprocessing workflow with an emphasis on how transfection conditions influence the outcome of protein production.
- Introduction into bioproduction and transient protein production
- Experimental conditions: transfection, protein expression, cell viability, scalability
This webinar will be held on June 02nd, 2016 at 10:00 a.m. and 7.00 p.m. CET.
02. June 2016, 10:00, CET
Dr. Thomas Schreiber, Mathieu Porte
A new approach in adventitious virus testing in biopharmaceutical production
In cooperation with INFORMA we perform a webinar to introduce the new ViroInspect® Rodent 2 Test Kit for the detection and identification of viruses in biological materials.
Overview of the presentation:
- Contamination of cell cultures by viruses is a fundamental problem for the manufacture of biopharmaceutical products
- Biopharmaceutical production must comply with different legal requirements and regulatory bodies all over the world
- Cell culture and in vivo susceptibility test are still used as standard methods but suffer from many disadvantages such as time, sample throughput, serviceability, specificity, sensitivity, ethical aspects and overall costs
- New techniques for rapid and comprehensive virus detection have been developed and validated in accordance with legal guidelines
- With results delivered in less than 9 hours, ViroInspect® Rodent 1 and Rodent 2 from Greiner Bio-One are a rapid and effective alternative to cell culture and in vivo testing
Webinar Date: June 1st, 2016 – 15.00 CET / 14.00 BST / 9.00 EDT
01. June 2016, 15:00, CET
Dr. Kristina Hänel, Key Account Manager, Biopharm. Applications
Revisiting A Common Lab Test - A Review of Urinalysis and Urine Culture
- Describe the preanalytical requirements for urine and urine culture
- Identify current practices in analytical testing of urine
- Correlate biochemical findings with select clinical conditions
- Describe the process of urine culture for select patient populations
About the Speaker:
Beth Warning, MS, MLS (ASCP) is faculty with the MLS Program at the University of Cincinnati.
Prior to academia, Beth had extensive experience in a large, multi-location medical center, working in hematology, toxicology, and chemistry. Over a career spanning 25 years with the same facility, she advanced to Laboratory Director for the rural access and immediate response labs. She is active in promoting the profession of laboratory science to area high schools, and serves on both state and national professional committees.
P.A.C.E® Instruction Level: Intermediate
P.A.C.E® Credits Earned Upon Completion: 1
17. March 2016, 13:00, EDT
Phlebotomy Draw Volumes: Contribution to Hospital-Acquired Anemia
This webinar was held on October 22nd, 2015 at 1:00pm eastern time. The event lasted for approximately 60 minutes and each participant will receive 1.0 P.A.C.E credit hour for attending.
Several studies have shown evidence of diagnostic laboratory testing as a major contributor to hospital-acquired anemia (HAA). The frequency and volume of blood collection leads to blood loss from laboratory testing (BLLT), which can be significant in hospitalized adults. Over time, this excess blood collection can lead to lower hemoglobin concentrations. We will discuss the effects of hospital-acquired anemia (HAA) and how laboratories can participate in preventing it.
Points of discussion in this webinar will include:
- Define hospital-acquired (iatrogenic) anemia (HAA) and describe the primary causes.
- Describe how laboratory practice and ordering patterns contribute to HAA.
- Describe possible solutions to prevent HAA.
Presenter: Chelsea Grinols, MLS (ASCP)
Chelsea Grinols (MLS, ASCP) has worked in, and in collaboration with clinical laboratories since 2005. After several years as a clinical laboratory scientist, she began working in healthcare process improvement focusing on laboratory practices; particularly pre-analytical operations. She is a certified Six Sigma Black Belt and is also certified in Design for Six Sigma.
22. October 2015, 13:00, Eastern
Greiner Bio-One North America, Inc.